title: Clinical and radiographic evaluation of pulpotomies in primary molars with formocresol, glutaraldehyde and ferric sulphate.
abstract: OBJECTIVE
  This in vivo study aimed to assess and compare the relative clinical and radiographic success of formocresol, glutaraldehyde and ferric sulphate as medicaments following pulpotomies in primary molars at three-monthly intervals over one year.
  
  
  METHODS
  The study was carried out on 90 primary molars in 54 children aged from 3 to 9 years. Selected teeth were equally distributed and randomly assigned to formocresol, glutaraldehyde and ferric sulphate pulpotomy medicament groups (30 in each group). The teeth were then evaluated clinically and radiographically at three-monthly intervals over one year. The resulting data were tabulated and statistically analysed using the chi-square test.
  
  
  RESULTS
  After one year, the clinical success rate was 100% with glutaraldehyde, 96.7% with ferric sulphate, and 86.7% with formocresol. The radiological success rate gradually decreased over the year in all pulpotomy medicament groups. Radiological success rates in formocresol, glutaraldehyde, and ferric sulphate groups were 56.7%, 83.3%, and 63.3%, respectively.
  
  
  CONCLUSIONS
  Two per cent glutaraldehyde may be recommended as a more effective alternative to formocresol and ferric sulphate as a pulpotomy medicament.
authors.affiliation: Department of Paediatric and Preventive Dentistry, AME's Dental College, Hospital, and Research Centre, Raichur, Karnataka, India. raghavendravale@yahoo.co.in
authors.forename: Raghavendra
authors.initials: R
authors.lastname: Havale
authors.forename: Rajesh T
authors.initials: RT
authors.lastname: Anegundi
authors.forename: Kr
authors.initials: K
authors.lastname: Indushekar
authors.forename: P
authors.initials: P
authors.lastname: Sudha
mesh_terms: D002648:Child; D002675:Child, Preschool; D003442:Crowns; D003722:Dental Alloys / Q000737:chemistry; D004487:Edema / Q000209:etiology; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005566:Formocresols / Q000627:therapeutic use*; D005899:Glass Ionomer Cements / Q000737:chemistry; D005976:Glutaral / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008963:Molar / Q000000981:diagnostic imaging / Q000601:surgery*; D010483:Periapical Diseases / Q000209:etiology; D011672:Pulpotomy / Q000379:methods*; D011859:Radiography; D012388:Root Canal Irrigants / Q000627:therapeutic use*; D013193:Stainless Steel / Q000737:chemistry; D014091:Tooth Resorption / Q000209:etiology; D014094:Tooth, Deciduous / Q000000981:diagnostic imaging / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D003722:Dental Alloys; D005290:Ferric Compounds; D005566:Formocresols; D005899:Glass Ionomer Cements; D012388:Root Canal Irrigants; D013193:Stainless Steel; C031025:formocresol; C024823:ferric sulfate; D005976:Glutaral